Assessing the integration of skin screening into a mass drug administration campaign against neglected tropical diseases: A cross-sectional observational study from two districts in Côte d'Ivoire, 2023

•An integrated campaign of skin screening and mass drug administration is feasible.•Cost savings may not be a guaranteed outcome of an integrated campaign.•People in remote areas appreciate a comprehensive service package in a campaign.•Campaign quality can be improved with better planning, training...

Full description

Saved in:
Bibliographic Details
Published in:International journal of infectious diseases Vol. 147; pp. 107177 - None
Main Authors: Huang, Xiao Xian, Kone, Bognan Valentin, Koffi, Yao Didier, Koffi, Aboa Paul, Camara, Poplikla Blanche Euphraise, DJE, Laurence, Kouma, Brahima, AKPA, M. Amari Jules Cesar, N'DRI, N'goran Raphaël, Barogui, Mahoutondji Yves Thierry, Asiedu, Kingsley Bampoe
Format: Journal Article
Language:English
Published: Canada Elsevier Ltd 01-10-2024
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•An integrated campaign of skin screening and mass drug administration is feasible.•Cost savings may not be a guaranteed outcome of an integrated campaign.•People in remote areas appreciate a comprehensive service package in a campaign.•Campaign quality can be improved with better planning, training, and supervision. The World Health Organization advocates integrating neglected tropical diseases (NTDs) into common delivery platforms to combat them in resource-constrained settings. However, limited literature exists on the benefits of integration. This study examines the feasibility and impact of adding skin screening to a mass drug administration (MDA) campaign in Côte d'Ivoire. In June 2023, the Ministry of Health and Public Hygiene of Côte d'Ivoire piloted screening for skin-related NTDs alongside a national MDA campaign targeting soil-transmitted helminthiases and schistosomiasis. Two districts, Fresco and Koro, were selected for the pilot. The study applied both quantitative and qualitative assessments. The quantitative aspect focused on campaign costs and outputs, using an ingredient approach for costing. The qualitative evaluation employed an empirical phenomenological approach to analyze the campaign's operational feasibility and appreciation by stakeholders. MDA activities cost $0·66 per treated child and skin screening $0·62 per screened person, including medical products. The MDA campaign exceeded coverage targets in both districts, whereas skin screening coverage varied by locality and age group. Both the service delivery team and the beneficiaries expressed appreciation for the integrated campaign. However, opportunities for improvement were identified. Integrating MDA and skin NTD screening proved operationally feasible in this context but had not recorded cost-saving effects. The performance of the MDA campaign was not negatively affected by additional skin screening activities, but effective integration requires thorough joint planning, strengthened training, and proper supervision.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:1201-9712
1878-3511
1878-3511
DOI:10.1016/j.ijid.2024.107177